Lundbeck
Julie Klint

Director, Head of Molecular Discovery & Enabling Technologies division at Lundbeck

About me

Julie Klint, serves as the Director of Molecular Discovery and Enabling Technologies at Lundbeck Research. She earned a Master of Pharmaceutical Sciences from Copenhagen University and a PhD from the University of Queensland, specializing in Ion channel Drug discovery. After a few years as a Research Leader at Evotec AG, Automated Patch Clamp facility in Hamburg, Germany, she joined Lundbeck in Copenhagen, Denmark. At Lundbeck, she is a core member of the Research Leadership team and plays a pivotal role in advancing innovative Drug Discovery projects in the field of Neuroscience. Her leadership is driving research projects, through cutting edge technologies and the integration of Generative AI and predictive modeling to transform drug discovery processes. She is responsible for the Digital strategy of Lundbeck Research and is leading the implementation of Research Scientific data system and application platforms, enhancing lab automation and implementing FAIR data principles.

Schedule

My Session

Novel technologies impacting drug discovery at Lundbeck

Julie Klint

Director, Head of Molecular Discovery & Enabling Technologies division at Lundbeck


Innovation in Drug Discovery
Drug Discovery and Development
Panel Discussion - Empowering drug discovery and development: the AI and Machine Learning revolution?
  • How pharmaceutical companies are adopting AI to discover new drugs and improve existing ones, and the impact this is having on their R&D strategies
  • How AI is not just a tool for research but is reshaping business models, leading to collaborations with tech companies, the rise of AI-driven biotech firms, and changes in investment strategies
  • Strategies to maximize AI & ML's impact in drug discovery and development
  • Mitigating risks and uncertainties in drug development through AI. Explore how AI is being used to navigate the complexities of both early-stage discovery and late-stage clinical trials

AI and ML in Pharma
Innovation in Drug Discovery

Paul Agapow

Advisor at Bayezian

Julie Klint

Director, Head of Molecular Discovery & Enabling Technologies division at Lundbeck

Calvin Chan

Product Manager - Medical Affairs Analytics at Roche

Ammara Gafoor

Head of Healthcare & Life Sciences , Europe at Thoughtworks